1-8 of 8
Øystein Bruserud, MD PhD
Close
Sort by
Journal Articles

The Transmembrane Protein CD37 Is Not a Promising Therapeutic Target in Acute Myeloid Leukaemia

Tara Helen Dowling Dowling Steinsland, MSc, Stein-Erik Gullaksen, MS, PhD, Geir Bredholt, PhD, Calum Leitch, PhD, Mireia Mayoral Safont, BS, Øystein Bruserud, MD PhD, Mihaela Popa, Astri Maaland, Helen Heyerdahl, PhD, Jostein Dahle, PhD, Bjorn T. Gjertsen, MD PhD, Emmet Mccormack, BSc, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-142899
Published: 2020
Journal Articles

Development of Novel Highly Specific FLT3 Targeted Inhibitors for Combination or Sequential Therapy of Acute Myeloid Leukemia

Misbah Sabir, MSc, Monica Hellesoy, PhD, Jarno Kivioja, MSc, Caroline Engen, MD, Claire Amiable, Mihaela Popa, Remi Guillon, Øystein Bruserud, MD PhD, Caroline A Heckman, PhD, Emmet McCormack, BSc, PhD, Dominique Surleraux, Bjørn Tore Gjertsen
Journal: Blood
Blood (2017) 130 (Supplement 1): 3349.
https://doi.org/10.1182/blood.V130.Suppl_1.3349.3349
Published: 2017
Journal Articles

Single Cell Signaling Pharmacodynamics in a Phase 1b Trial of the Axl Inhibitor BGB324 in Acute Myeloid Leukemia

Monica Hellesøy, PhD, Stein-Erik Gullaksen, Benedicte Sjo Tislevoll, Oda Helen Eck Fagerholt, Hakon Reikvam, MD PhD, Sonja Loges, MD PhD, Jorge Cortes, MD, Michael Heuser, MD, Jörg Chromik, Jørn Skavland, PhD, André Sulen, Øystein Bruserud, MD PhD, Jim Lorens, PhD, Gro Gausdal, PhD, David Micklem, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3995.
https://doi.org/10.1182/blood.V128.22.3995.3995
Published: 2016
Journal Articles

Survival Stratification In Acute Myeloid Leukemia By Single Cell Signal Profiling

Jørn Skavland, PhD, Håkon Reikvam, MD/PhD, Øystein Bruserud, MD, PhD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2013) 122 (21): 2625.
https://doi.org/10.1182/blood.V122.21.2625.2625
Published: 2013
Journal Articles

Myeloid Derived Suppressor Cell Expansion Correlates With Increased regulatory T Cells In Myelodysplastic Syndrome

Astrid Olsnes Kittang, MD, PhD, Shahram Kordasti, MD, PhD, Kristoffer Evebø Sand, MD, Pilar Perezabellan, Thomas Seidl, Kristin Paulsen Rye, Karen Marie Hagen, Geir Hallan, MD, PhD, Austin G Kulasekararaj, MD, PhD, Øystein Bruserud, MD, PhD, Ghulam J. Mufti, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2766.
https://doi.org/10.1182/blood.V122.21.2766.2766
Published: 2013
Journal Articles

Elacytarabine Is More Effective Preclinically Than Cytarabine In Combination With Daunorubicin In Primary Patient Xenografts Of AML

Tereza Osdal, MSc, Mihaela Lucia Popa, VMD, Lene Mari Vikebø, Andre Sulen, MSc, Siv Lise Bendringaas, Marit Liland Sandvold, PhD, Birgitte Booij, PhD, Øystein Bruserud, MD, PhD, Bjørn Tore Gjertsen, MD, PhD, Emmet McCormack, PhD
Journal: Blood
Blood (2013) 122 (21): 3958.
https://doi.org/10.1182/blood.V122.21.3958.3958
Published: 2013
Journal Articles

Serum Heat Shock Protein Levels and Cytokine Profiles Are Altered In AML Patients Before Treatment and Following Disease Stabilizing Therapy,

Hanne Fredly, MD, Håkon Reikvam, MD, Bjorn T. Gjertsen, MD, PhD, Øystein Bruserud, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3599.
https://doi.org/10.1182/blood.V118.21.3599.3599
Published: 2011
Journal Articles

Flt3 Mutations in Proximity to an Ubiquitin Dependent Endocytosis Motif Suspend Its Hdm2 Modulation.

Line Wergeland, PhD, Eystein Oveland, MSc, Gry Sjoholt, PhD, Siv Lise Bedringaas, MSc, Randi T. Hovland, PhD, Oystein Bruserud, MD, PhD, Bjorn T. Gjertsen, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4320.
https://doi.org/10.1182/blood.V110.11.4320.4320
Published: 2007